Crocs, Inc. (CROX) Faces Securities Class Action over HEYDUDE Pipeline – Hagens Berman — Neutral
CROX GlobeNewsWire — February 10, 2025SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Investors in Crocs, Inc. (NASDAQ: CROX) suffered yet another loss on Oct. 29, 2024 after the company prepared investors for disappointing Q4 and FY 2024 financial results that, in turn, sent shares crashing $26.47 (-19%). According to the company, the culprit was its HEYDUDE operating segment performance. Now a class action lawsuit has been filed focused on the propriety of Crocs' disclosures about sales practices within its HEYDUDE operating segment, which Crocs acquired in mid-February 2022.

Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - REGN — Neutral
REGN Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=128474&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Pacira Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRX — Neutral
PCRX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=128478&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Shareholders of AstraZeneca PLC (AZN) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
AZN Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=128477&wire=1 or contact Joseph E. Levi, Esq.

Greener Pastures New Zealand Celebrates Visa Changes to Welcome High Value Citizens, Announced by Prime Minister Christopher Luxon — Neutral
V Business Wire — February 10, 2025AUCKLAND, New Zealand--(BUSINESS WIRE)--Greener Pastures New Zealand, a premier investment and lifestyle advisory firm specializing in facilitating high-net-worth investor residency through New Zealand's Active Investor Plus (AIP) visa program, welcomes the significant immigration changes announced on Sunday by Prime Minister Rt Hon Christopher Luxon, Finance Minister Hon Nicola Willis, and Immigration Minister Hon Erica Stanford at the Auckland Business Chamber's special session on Immigration.

Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design – Hagens Berman — Neutral
NVO GlobeNewsWire — February 10, 2025SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk A/S (NYSE: NVO) is facing a class-action lawsuit from investors who allege the pharmaceutical giant misled them about the prospects of its experimental obesity drug, CagriSema. Hagens Berman urges investors who purchased Novo Nordisk shares and suffered substantial losses to submit your losses now.

AIQ: Sustaining The Current Uptrend With Higher AI Adoption & Spending — Positive
AIQ Seeking Alpha — February 10, 2025I rate Global X Artificial Intelligence & Technology ETF a buy due to its strong performance, high liquidity, and diverse holdings compared to peers. AIQ's high liquidity, lower expense ratio, and diversified holdings across multiple sectors make it a superior investment choice over LRNZ and THNQ. AIQ has demonstrated solid performance, gaining 45.79% over three years, and is supported by bullish technical indicators and growing AI adoption.

Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to explain why he's buying back into Uber after Bill Ackman announced a position in the ridesharing company.

Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman — Neutral
CDLX GlobeNewsWire — February 10, 2025SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Cardlytics, the advertising technology company that connects marketers with consumers through their banking apps, is facing a class-action lawsuit alleging that it misled investors about its growth prospects. Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now.

Final Trades: NRG Energy, MP Materials, CareDx and Applovin — Neutral
APP CDNA MP NRG CNBC Television — February 10, 2025The Investment Committee give you their top stocks to watch for the second half.

Stagwell (STGW) Agencies 72andSunny, Allison, Anomaly, Code and Theory, Colle McVoy, HUNTER, Jasper Advisors and Trade X Partners Deliver Standout Moments During and Surrounding Super Bowl LIX — Neutral
STGW PRNewsWire — February 10, 2025Three Spots Earned Top 10 Honors from USA Today Ad Meter NEW YORK and NEW ORLEANS , Feb. 10, 2025 /PRNewswire/ -- Stagwell, the challenger network built to transform marketing, and its network of award-winning agencies aired four standout spots during this year's Super Bowl LIX for clients Bud Light, the National Football League (NFL) and Starbucks. Alongside the Big Game, Stagwell agencies led high-impact off-field campaigns and activations for clients including Budweiser, Booking.com, Don Julio, Frank's RedHot, GoDaddy, Perdue Chicken and more.

FTAI Aviation Ltd. (NASDAQ: FTAI) Faces Intensified Scrutiny Following Second Short-Seller Report Amid Investor Class Action – Hagens Berman — Neutral
FTAI GlobeNewsWire — February 10, 2025SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI) is facing mounting pressure after a second activist short-seller, Snowcap, released a critical report on January 29, 2025, further amplifying concerns initially raised by Muddy Waters Research earlier in January and leading to an investor class action alleging securities fraud.

FMC Corporation (FMC) Shares Tumble 33% After Inventory Destocking Continues – Hagens Berman — Neutral
FMC GlobeNewsWire — February 10, 2025SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Shares in FMC Corporation (NYSE: FMC) plummeted 33% on Feb. 5, wiping out over $2 billion in shareholder value, after the agricultural sciences company issued a disappointing earnings report and outlook that clashed with previous assurances about executives made about the business.

Mobileye (MBLY 14.90%) stock is rocketing higher in Monday's trading. The machine vision specialist's share price was up 16.4% as of 1 p.m.

Super Micro Computer (SMCI 13.71%) stock is surging in Monday's trading. The server company's share price was up 11.1% as of 12:30 p.m.

EGAN to Report Q2 Earnings: What's in the Cards for the Stock? — Neutral
EGAN Zacks Investment Research — February 10, 2025eGain is expected to have gained from strong AI-driven bookings and renewals, though a cautious outlook is likely to have limited growth in Q2.

Amy Raskin, Chief Investment Officer at Chevy Chase Trust, joins CNBC's Halftime Report to explain why she's trimming the quantum computer company.

Brady Corporation Announces Earnings Conference Call — Neutral
BRC GlobeNewsWire — February 10, 2025MILWAUKEE, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE: BRC), will announce its fiscal 2025 second quarter financial results on Friday, February 21, 2025.

Manhattan Associates (MANH) Shares Tumble 24% After Citing Headwinds for Services Business & Revealing 2025 GAAP EPS Expected to Shrink – Hagens Berman — Neutral
MANH GlobeNewsWire — February 10, 2025SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- On Jan. 29, 2025, the price of software solutions company Manhattan Associates, Inc. (NASDAQ: MANH) tumbled $72.26 lower (-24%) after reporting its Q4 and FY 2024 financial results and providing 2025 revenue guidance which was below analysts' consensus estimates. Hagens Berman urges Manhattan Associates investors who suffered substantial losses to submit your losses now.

Mereo Insurance Limited Launches into Attractive Reinsurance Market — Neutral
ARES Business Wire — February 10, 2025HAMILTON, Bermuda--(BUSINESS WIRE)--Mereo Insurance Limited, a new reinsurance platform, has received an A- credit rating from AM Best, and begins operations this week in an attractive global property and casualty reinsurance market. The common equity was led by Susquehanna Private Equity Investments, LLLP, a member of the Susquehanna International Group of Companies, and The Andover Companies, with preferred equity provided by Ares Management Alternative Credit funds (“Ares”). This first close.
